Detection of P2Y14 protein in platelets and investigation of the role of P2Y1414 in platelet function in comparison with the EP 3 receptor

Thrombosis and Haemostasis

Volumn 100, Issue 2, 2008, Pages 261-270

  Dovlatova, Natalia ^a,c   Wijeyeratne, Yanushi D ^a   Fox, Susan C ^a   Manolopoulos, Panagiotis ^a   Johnson, Andrew J ^a   White, Ann E ^a   Latif, M Liaque ^b   Ralevic, Vera ^b   Heptinstall, Stanley ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

EP 3; GPR105; KIAA0001; P2Y12; P2Y14; P2Y1; Platelet aggregation; Sulprostone; UDP glucose

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENYLATE CYCLASE; CANGRELOR; EP3 RECEPTOR; PROSTAGLANDIN RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y14 RECEPTOR; SULPROSTONE; URIDINE DIPHOSPHATE GLUCOSE; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA;

ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ANIMALS; BLOOD PLATELETS; CELL ADHESION MOLECULES; DINOPROSTONE; HUMANS; IMMUNOBLOTTING; MICROFILAMENT PROTEINS; MICROSCOPY, CONFOCAL; PHOSPHOPROTEINS; PHOSPHORYLATION; PLATELET AGGREGATION; PLATELET COUNT; RATS; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, PURINERGIC P2; URIDINE DIPHOSPHATE GLUCOSE;

EID: 48949084626     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-10-0601     Document Type: Article

References (31)

1. Gentry PA. The mammalian blood platelet: its role in haemostasis, inflammation and tissue repair. J Comp Pathol 1992; 107: 243-270.
2. Blann AD, Lip GY. Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets. Thromb Res 2001; 101: 321-327.
3. Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003; 23: 2131-2137.
4. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378-3384.
5. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50: 413-492.
6. Gachet C. Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 2006; 46: 277-300.
7. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 2006; 58: 58-86.
8. Nomura N, Miyajima N, Sazuka T, et al. Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. DNA Res 1994; 1: 47-56.
9. 14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 2003; 24: 52-55.
10. Moore DJ, Murdock PR, Watson JM, et al. GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function. Mol Brain Res 2003; 118: 10-23.
11. Tolhurst G, Vial C, Leon C, et al. Interplay between P2Y(1), P2Y(12), and P2X(1) receptors in the activation of megakaryocyte cation influx currents by ADP: evidence that the primary megakaryocyte represents a fully functional model of platelet P2 receptor signaling. Blood 2005; 106: 1644-1651.
12. Chambers JK, Macdonald LE, Sarau HM, et al. A G protein-coupled receptor for UDP-glucose. J Biol Chem 2000; 275: 10767-10771.
13. + and IL-8 secretion. Am J Respir Cell Mol Biol 2005; 33: 601-609.
14. 14 receptor in murine T-lymphocytes. Br J Pharmacol 2005; 146: 435-444.
15. 14 receptor in human neutrophils. Eur J Pharmacol 2006; 543: 166-173.
16. Lazarowski ER, Shea DA, Boucher RC, et al. Release of cellular UDP-glucose as a potential extracellular signaling molecule. Mol Pharmacol 2003; 63: 1190-1197.
17. 14) and increase intracellular calcium in response to its agonist, uridine diphosphoglucose. J Immunol 2003; 171: 1941-1949.
18. Matthews JS, Jones RL. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues. Br J Pharmacol 1993; 108: 363-369.
19. 3 prostaglandin receptor subtypes. Prostaglandins 1996; 52: 175-185.
20. Ma H, Hara A, Xiao CY, et al. Increased bleeding tendency and decreased susceptibility to thromboembolism in mice lacking the prostaglandin E receptor subtype EP(3). Circulation 2001; 104: 1176-1180.
21. Paul BZ, Ashby B, Sheth SB. Distribution of prostaglandin IP and EP receptor subtypes and isoforms in platelets and human umbilical artery smooth muscle cells. Br J Haematol 1998; 102: 1204-1211.
22. Wallen NH, Ladjevardi M, Albert J, et al. Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular mass heparin and hirudin. Thromb Res 1997; 87: 151-157.
23. 2) receptor; pharmacological and kinetic studies in vitro. Platelets 2003; 14: 359-374.
24. 1 receptor in vitro. Platelets 2003; 14: 445-462.
25. 3 Receptors: A new target for inhibition of platelet function in inflammatory thrombotic disease. Arterioscler Thromb Vasc Biol 2007; 27: e109
26. 2T receptor: a novel approach to antithrombotic therapy. J Med Chem 1999; 42: 213-220.
27. Fox SC, Sasae R, Janson S, et al. Quantitation of platelet aggregation and microaggregate formation in whole blood by flow cytometry. Platelets 2004; 15: 85-93.
28. Stafford NP, Pink AE, White AE, et al. Mechanisms involved in adenosine triphosphate-induced platelet aggregation in whole blood. Arterioscler Thromb Vasc Biol 2003; 23: 1928-1933.
29. Schwarz UR, Geiger J, Walter U, et al. Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets-definition and detection of ticlopidine/clopidogrel effects. Thromb Haemost 1999; 82: 1145-1152.
30. 14 receptor. J Med Chem 2007; 50: 2030-2039.
31. Freeman K, Tsui P, Moore D, et al. Cloning, pharmacology and tissue distribution of G-protein-coupled receptor GPR105 (KIAA0001) rodent orthologs. Genomics 2001; 78: 124-128.